Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits

Acta Neuropathologica

Volumn 100, Issue 1, 2000, Pages 82-86

  Yerroum, Mohammed ^a   Pham Dang, Christophe ^a   Authier, François Jérôme ^a,b   Monnet, Isabelle ^c   Gherardi, Romain ^a,b   Chariot, Patrick ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Cytochrome c oxidase; HIV; Mitochondria; Myopathy; Zidovudine

Indexed keywords

CELL NUCLEUS DNA; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME HISTOCHEMISTRY; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MALE; MYOPATHY; PRIORITY JOURNAL;

CHROMOSOMES; CYTOCHROME-C OXIDASE DEFICIENCY; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MITOCHONDRIAL MYOPATHIES; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DISEASES; ZIDOVUDINE;

EID: 0034088595     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010051196     Document Type: Article

References (32)

1. Arnaudo E, Dalakas M, Shanske S, Di Mauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337: 508-510
2. Capaldi RA (1990) Structure and function of cytochrome c oxidase. Annu Rev Biochem 59: 569-596
3. Chariot P, Gherardi R (1991) Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy. Neuromusc Disord 1: 357-363
4. Chariot P, Gherardi R (1995) Myopathy and HIV infection. Curr Opin Rheumatol 7: 497-502
5. Chariot P, Monnet I, Gherardi R (1993) Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy. Ann Neurol 34: 561-565
6. Chariot P, Benbrik E, Schaeffer A, Gherardi R (1993) Tubular aggregates and partial cytochrome c oxidase deficiency in skeletal muscle of patients with AIDS treated with zidovudine. Acta Neuropathol 85: 431-436
7. Chariot P, Bonne G, Authier FJ, Marsac C, Gherardi R (1994) Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy. J Neurol Sci 125: 190-193
8. Chariot P, Monnet I, Mouchet M, et al (1994) Blood lactate/ pyruvate ratio as a noninvasive test for the detection of zidovudine myopathy. Arthritis Rheum 37: 583-586
9. Chariot P, Ruet E, Authier FJ, Labes D, Gherardi R (1996) Mitochondrial dysfunction in the muscle of patients with inflammatory myopathies. Acta Neuropathol 91: 530-536
10. Chariot P, Drogou I, de Lacroix-Szmania I, et al (1999) Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol 30: 156-160
11. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis J, Cohen J, Griffin J (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322: 1098-1105
12. DiMauro S, Hirano M, Bonilla E, Moraes CT, Schon EA (1994) Cytochrome c oxidase deficiency: progress and problems. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford, pp 91-115
13. Hayashi JI, Tanaka M, Sato W, et al (1990) Effects of ethidium bromide treatment of mouse cells on expression and assembly of nuclear-coded subunits of complexes involved in the oxidative phosphorylation. Biochem Biophys Res Commun 167: 216-221
14. Herzberg N, Middelkoop E, Adorf M, et al (1993) Mitochondria in cultured human muscle cells depleted of mitochondrial DNA. Eur J Cell Biol 61: 401-408
15. Hobbs GA, Keilbaugh SA, Rief PM, Simpson MV (1995) Cellular targets of 3'azido-3'deoxythymidine: an early (non delayed) effect on oxidative phosphorylation. Biochem Pharmacol 50: 381-390
16. King MP, Attardi G (1989) Human cells lacking mtDNA: re-population with exogeneous mitochondria by complementation. Science 246: 500-503
17. Lewis W, Dalakas MC (1995) Mitochondrial toxicity of antiviral drugs. Nat Med 1: 417-422
18. Lewis W, Gonzalez B, Chomyn A, Papoian T (1992) Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 89: 1354-1360
19. Lombès A, Mendell JR, Nakase H, et al (1989) Myoclonic epilepsy and ragged-red fibers with cytochrome c oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann Neurol 26: 20-33
20. Mariotti C, Uziel G, Carrara F, et al (1995) Early-onset encephalomyopathy associated with tissue specific mitochondrial DNA depletion: a morphological, biochemical and molecular-genetic study. J Neurol 242: 547-556
21. Martin JL, Brown CE, Matthews-Davis N, Reardon JE (1994) Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother 38: 2743-2749
22. Matsuoka T, Goto Y-I, Hasegawa H, Nonaka I (1992) Segmental cytochrome c oxidase deficiency in CPEO: teased muscle fiber analysis. Muscle Nerve 15: 209-213
23. Matsuoka T, Goto Y-I, Yoneda M, Nonaka I (1992) Muscle histopathology in myoclonus epilepsy with ragged-red fibers (MERRF). J Neurol Sci 106: 193-198
24. Mhiri C, Baudrimont M, Bonne G, et al (1991) Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 29: 606-614
25. Moraes CT, Shanske S, Tritschler HJ, et al (1991) mt DNA depletion with variable tissue expression : a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48: 492-501
26. Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C (1995) Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 54: 581-587
27. Papadimitriou A, Comi GP, Hadjigeorgiou GM, et al (1998) Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology 51: 1086-1092
28. Schröder JM, Bertram M, Schnabel R, Pfaff U (1992) Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine. Acta Neuropathol 85: 39-47
29. Schröder JM, Kaltenbach T, Piroth W (1996) Nuclear and mitochondrial changes of co-cultivated spinal cord, spinal ganglia and muscle fibers following treatment with various doses of zidovudine. Acta Neuropathol 92: 138-149
30. Taanman JW, Bodnar AG, Cooper JM, et al (1997) Molecular mechanisms in mitochondrial DNA depletion syndrome. Hum Mol Genet 6: 935-942
31. Tritschler HJ, Andreetta F, Moraes CT, et al (1992) Mitochondrial myopathy of childhood associaited with depletion of mitochondrial DNA. Neurology 42: 209-217
32. Vu TH, Tanji K, Valsamis H, Di Mauro S, Bonilla E (1998) Mitochondrial DNA depletion in a patient with long survival. Neurology 51: 1190-1193